Cardiovascular Events During Differing Hypertension Therapies in Patients With Diabetes
暂无分享,去创建一个
[1] G. Bakris,et al. 24-hour ambulatory blood pressure in the ACCOMPLISH trial. , 2010, The New England journal of medicine.
[2] G. Bakris,et al. Cardiovascular events during differing hypertension therapies in patients with diabetes. , 2010, Journal of the American College of Cardiology.
[3] Kevin A Peterson,et al. Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus , 2011 .
[4] G. Bakris,et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. , 2008, The New England journal of medicine.
[5] G. Bergus,et al. Comparative Antihypertensive Effects of Hydrochlorothiazide and Chlorthalidone on Ambulatory and Office Blood Pressure , 2006, Hypertension.
[6] B. Davis,et al. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2002, JAMA.
[7] S. Yusuf,et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .